U.S. Senate hopeful Dr. Rik Mehta is a biotech entrepreneur, innovator, healthcare policy expert and a licensed pharmacist and attorney. Trained at world–renowned Rutgers University as a pharmacist and lawyer, Dr. Mehta has emerged as a top potential candidate for the U.S. Senate seat in 2020 because of his intimate knowledge of the issues that matter to New Jersey. As a small business owner and a first generation American, he’s a staunch advocate for defending our Constitutional rights, fighting against illegal immigration and Sanctuary Cities, an affordable, accessible healthcare system that’s built for generations to come, and building New Jersey’s economy for the future.
Rik’s professional career expands both the public and the private sectors. Currently, Rik is a co-founder and sits on the Board of two privately-held companies; Licentiam, Inc. and Lactiga Therapeutics. The first is a regulatory technology firm built to reduce paperwork burdens imposed on doctors by state governments. The latter is a biotherapeutics company developing novel, oral immunoglobulin treatments targeting rare diseases. Rik is also the Principal of his own consulting firm, R&R Strategies, that helps companies navigate regulatory processes created by government administrations in the healthcare space.
In the public sector, Rik worked at the United States Food and Drug Administration as a Consumer Safety Officer to advance policies to expedite and increase access to quality, affordable drugs and health care. He also enforced against pharmaceutical companies taking millions of illegal prescription opioids off the market. Rik has deep expertise untangling the unnecessarily complicated regulations that make drugs expensive and healthcare unaffordable. He knows we need real healthcare reform driven by competition and innovation, not government control.
Rik lives in Morris County where he and his wife Reema raise their three little gentlemen and their dog Dexter. Rik’s energetic wife, Reema, is also an influential leader and scientist. She is a former FDA official and currently works as a drug safety science leader at Pfizer where she is also a member on the FDA Advisory Committee in drug safety and risk management. The two met at their alma mater, Rutgers University-New Brunswick, where they married.
Rik received his B.S. in pharmacy from Rutgers University, his Pharm.D. from the University of Arkansas for Medical Sciences, his J.D. from Rutgers University School of Law and a Master of Laws in Global Health Law and International Institutions through a joint program with Georgetown University Law Center and the Graduate Institute for International and Development Studies in Geneva, Switzerland.